Wegovy Weight Loss Journey

£195.00

Once-weekly GLP-1 injection clinically approved for long-term weight management 

  • Mechanism: GLP-1 receptor agonist 

  • How it works: Regulates hunger, improves satiety, reduces food cravings 

  • Ideal for: Adults with a BMI ≥30 or ≥27 with weight-related health conditions 

  • Dosage: Once weekly, increasing gradually over 4–8 weeks 

  • Results: Average weight loss of 10–15% of total body weight with consistent use and lifestyle support 

  • Availability: MHRA-approved, prescribed only after full medical screening 

Wegovy Weight Loss Journey

Wegovy Weight Loss Journey

£195.00

£195.00

Empower Your Metabolic Health with Confidence

At La Rose Clinic, Wegovy injections (semaglutide) are medically approved for safe and effective weight loss. This state-of-the-art solution is suitable for clients seeking sustainable weight management without surgery, with scientifically proven effectiveness.

How Does It Work?

Wegovy is a semaglutide—based injectable drug that mimics the action of the natural hormone GLP-1, which regulates appetite and satiety. It affects the hunger centersin the brain, helping you:

  • Eat less and feel full longer
  • Reduce your total calorie intake
  • Increase weight control and eating habits

It is used once a week under the supervision of a doctor. Wegovy has been clinically proven to help reduce weight by up to 15% of body weight while following a nutrition and activity program.

Who Is It For?

Wegovy injections are recommended for adults who:

  • Are overweight or obese (BMI ≥27 with concomitant conditions, or ≥30)
  • They strive for long-term weight loss under medical supervision
  • Have difficulty controlling their appetite
  • They want a safe, non-invasive alternative to surgical methods

Before starting therapy, a detailed consultation and medical screening are conducted.

What to Expect

  • Consultation: Assessment of the client's health status, weight history, and goals. Discussion of lifestyle and readiness for change.
  • Treatment: Weekly injections, prescribed and supervised by a specialist.
  • Monitoring: Regular monitoring, dosage adjustment, nutrition and activity support.
  • Results: The first results may appear in 4-6 weeks, the full effect — in 3-6 months.
  • Administration: Injections are self-administered at home after your first in-clinic demonstration. 

Additional Benefits

  • Improved appetite control and eating habits
  • Weight loss supported by medical supervision
  • Increased energy, improved well-being
  • It can improve sugar levels and metabolic functions.
  • Suitable for combination with procedures: IVS, contour correction, BIA analysis

Your Safety, Our Priority

All Wegovy injections are performed by qualified medical professionals in a CQC-certified clinic. We use only licensed medications and adhere to strict standards of medical safety and confidentiality.

Close-up of Asian girl lower face, hand and shoulder, highlighting smooth skin and calm expression

Need help choosing ?

We offer comprehensive consultations to help you understand your skin, body, and wellness needs. Whether you have a specific concern or simply want expert advice, our clinicians are here to guide you without pressure.

Book a Free Consultation

Treatment Length

30 min

Results Seen

4-6 weeks

Duration of Results

Sustainable with continued treatment and healthy lifestyle

Session Frequency

Weekly injections

Real Results

After

Before

La Rose Clinic Difference

What makes us different from other clinics

La Rose Clinic
Other Providers
Doctor-led treatments
Patient-Centric Environment
Advanced, Clinically proven treatments & products
CQC Registered

Wegovy® – Frequently Asked Questions

View all FAQs

Wegovy is a prescription-only, once-weekly semaglutide injection used alongside a reduced-calorie diet and increased physical activity for weight loss and long-term weight management. Approved for adults and youths aged 12+ with obesity, and adults with overweight plus at least one weight-related health condition. It also lowers the risk of serious cardiovascular events in adults with obesity and heart disease

Wegovy mimics the GLP‑1 hormone to reduce appetite and slow stomach emptying, helping users feel fuller, eat less, and lose weight

  • Adults (18+) with BMI ≥ 30 (obesity)
  • Adults with BMI ≥ 27 (overweight) plus at least one weight-related health issue (e.g., high blood pressure, diabetes, high cholesterol)
  • Adolescents aged 12+ with obesity

A gradual dose escalation over several months helps reduce gastrointestinal side effects:

  1. 0.25 mg weekly (weeks 1–4)
  2. 0.5 mg (weeks 5–8)
  3. 1.0 mg (weeks 9–12)
  4. 1.7 mg (weeks 13–16)
  5. Maintenance: 1.7 mg or 2.4 mg weekly from week 17 onward

Wegovy is administered as a subcutaneous injection under the skin (abdomen, thigh, or upper arm), once a week, with or without food. Rotate injection sites to minimize skin irritation

  • If more than 48 hours before your next scheduled dose: take the missed one ASAP.
  • If less than 48 hours remain: skip it and resume the regular schedule.
  • Missing more than two doses in a row? Consult your doctor—you might need to restart the escalation schedule

Clinical trials (STEP program) show an average weight loss of ~15% of initial body weight for both adults and adolescents. It has also been proven to lower the risk of heart attack, stroke, and cardiovascular death in adults with obesity and cardiovascular disease

Frequent side effects—often mild to moderate and transient—include:

  • Nausea (≈44%)
  • Diarrhea (30%), vomiting (24%), constipation (24%)
  • Abdominal pain (20%), headache (14%), fatigue (11%)
  • Gas, bloating, heartburn, belching, dizziness, injection-site reactions

Yes. Though rare, serious side effects may include:

  • Potential for thyroid C-cell tumors (based on rodent data)—report any neck lumps, hoarseness, or difficulty swallowing
  • Possible aspiration risk during surgery due to slowed gastric emptying—inform your providers if you’re on Wegovy
  • Hypoglycemia risk, especially in those with type 2 diabetes .

Try these tips:

  • Eat bland, low-fat foods (crackers, toast, rice)
  • Choose soups and gelatin
  • Avoid lying down right after eating
  • Eat slowly, stay hydrated, go for fresh air

Yes. It’s intended for long-term treatment when deemed safe and effective by your healthcare provider

No. Do not use Wegovy with other semaglutide products (e.g., Ozempic, Rybelsus) or other GLP‑1 receptor agonists